Physician profile
Oren G Epstein
NPI 1881719383
$1,516.46
in general payments reported to CMS, 2019-2025
13 companies · $539 in 2025
The $539 reported for 2025 was more than what 79% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $148 · 2021: $127 · 2022: $155 · 2023: $205 · 2024: $188 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $215.29 | 2024-2025 | Zip Ds Dressing Shield, Pangea |
| Bone Support INC. | $149.32 | 2025 | Cerament G, Ceramentbone Void Filler |
| Pacira Therapeutics, INC. | $148.03 | 2020 | |
| Medtronic USA, INC. | $140.24 | 2019 | |
| Avanos Medical | $127.64 | 2022 | |
| Endo USA, INC. | $123.04 | 2025 | Xiaflex |
| Genzyme Corporation | $121.82 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $121.64 | 2023 | Austedo Xr |
| Si-Bone, INC. | $114.28 | 2021 | |
| Zimmer Biomet Holdings, INC. | $111.08 | 2022-2023 | Persona |
| Solventum Corporation | $84.86 | 2025 | Prevena, Promogran Prisma |
| Djo, LLC | $41.08 | 2019-2024 | Procare |
| Ethicon US, LLC | $18.14 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oren Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.